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Abstract
Background: Infection with multiple types of human papillomavirus (HPV) is one of the main risk factors associated with the
development of cervical lesions. In this study, cervical samples collected from 1,810 women with diverse sociocultural
backgrounds, who attended to their cervical screening program in different geographical regions of Colombia, were
examined for the presence of cervical lesions and HPV by Papanicolau testing and DNA PCR detection, respectively.
Principal Findings: The negative binomial distribution model used in this study showed differences between the observed
and expected values within some risk factor categories analyzed. Particularly in the case of single infection and coinfection
with more than 4 HPV types, observed frequencies were smaller than expected, while the number of women infected with 2
to 4 viral types were higher than expected. Data analysis according to a negative binomial regression showed an increase in
the risk of acquiring more HPV types in women who were of indigenous ethnicity (+37.8%), while this risk decreased in
women who had given birth more than 4 times (231.1%), or were of mestizo (224.6%) or black (240.9%) ethnicity.
Conclusions: According to a theoretical probability distribution, the observed number of women having either a single
infection or more than 4 viral types was smaller than expected, while for those infected with 2–4 HPV types it was larger
than expected. Taking into account that this study showed a higher HPV coinfection rate in the indigenous ethnicity, the
role of underlying factors should be assessed in detail in future studies.
Citation: Soto-De Leon S, Camargo M, Sanchez R, Munoz M, Perez-Prados A, et al. (2011) Distribution Patterns of Infection with Multiple Types of Human
Papillomaviruses and Their Association with Risk Factors. PLoS ONE 6(2): e14705. doi:10.1371/journal.pone.0014705
Editor: Karin E. Peterson, Rocky Mountain Laboratories, NIAID, NIH, United States of America
Received July 19, 2010; Accepted January 28, 2011; Published February 17, 2011
Copyright:  2011 Soto-De Leon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was funded by Asociacion Investigacion Solidaria SADAR, Caja Navarra (Navarra, Spain) and the Spanish Agency for International
Development Cooperation (AECID) (Project 08-CAP2-0609). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: Despite the fact that "Caja Navarra" is a commercial funder, there are no conflicts regarding PLoS ONE policies on sharing data and
materials. No new patents or product developments apply to this study.
* E-mail: mapatarr.fidic@gmail.com
Introduction
Cervical cancer (CC) is one of the leading causes of cancer-
related death among women in developing countries [1]. Women
in South and East Africa, Central America and South America are
at greater risk of developing cervical cancer, with an average
annual incidence of 40 cases per 100,000 women [2]. In
Colombia, this disease has become a serious public health
problem, with an annual incidence of nearly 18.2 cases of cervical
cancer for every 100,000 women [3].
Persistent infection with one of the fifteen oncogenic types of
Human Papillomaviruses (HPVs) (commonly denoted as high-risk
HPV types (HR-HPV)) is considered the main risk factor associated
with this disease [4,5]. Different epidemiological studies have
suggested that about 50–75% of sexually active women are infected
with HPV at some point of their lives [6,7]. However, distribution
and prevalence of HPV infection rates vary largely between
geographical regions worldwide, probably as a consequence of the
numerous factors associated with HPV infection [8,9]. Even though
more than 180 types of HPV have been described, 15 of them are of
higher clinical interest due to their high association with malignant
disease and their strong mucosal tropism. Furthermore, the burden
of disease is mostly shared by 6 types (HPV-16, -18, -31, -33, -45,
-58) which are commonly reported in scientific literature as
responsible for the majority of lesions [9].
An important risk factor for developing cervical cancer is
coinfection, defined as infection with more than one HPV type. It
has been established that there is an important association between
the number of viral types at the site of infection and the severity of
the cervical intraepithelial neoplasia [10,11]. Of the total number
of women infected with HPV, about 20–50% is believed to be
infected with more than one viral type [12–14].
Other factors which contribute to the risk of developing cervical
cancer have been described, including age [15]; the lifetime
number of sexual partners, which has been especially associated
with coinfection [10]; cigarette smoking, although data regarding
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this aspect is controversial [16]; prolonged use of hormonal
contraceptives (reviewed in [2,16]); and a large number of full-
term pregnancies [17], among others. Recently, Almonte et al.
divided risk factors for Latin American populations into two
groups. The group of short-term risk factors included those related
to sexual behaviors, such as age at first sexual intercourse, lifetime
number of sexual partners and the sexual behavior of such
partners; while the group of long-term risk factors comprised the
use of oral contraceptives, high parity and cigarette smoking as
cofactors in cervical cancer etiology [18].
Nonetheless, these data are not definitive since discrepancies
concerning the factors that favor an increase in the severity of
cervical intraepithelial lesions exist, which are most likely related to
differences between the methodologies used for collecting samples
and laboratory detection methods [19], as well as between women
sociodemographic characteristics and sexual behaviors [20]. The
two later discrepancies stress the importance of establishing
associations between clinical and sociodemographic data with
molecular findings in HPV infection events, specific for genetically
diverse populations as the ones found in our country.
The present study involved 5 regions with different socio-cultural
and geographical characteristics, whose CC mortality rates ranged
between 3.12 and 5.67/100,000 inhabitants. These regions are:
Bogota, the country’s capital, with an urban population, which have
access to adequate health facilities. Leticia, localized in the
department of Amazonas, which is a tropical region inside the
colombian jungle characterized by its proximity to Peru and Brazil,
favored by high migration rates and an important ethnical diversity
with a predominant indigenous background. Chaparral, located in
the department of Tolima, is mainly constituted by mestizos with a
sedentary life style. Another region participating in this study was
Girardot, located in the department of Cundinamarca which due to
its favorable weather and great proximity to Bogota has become a
preferred touristic destination. It is worth noting that most of the
afore-mentioned regions display a predominantly mestizo popula-
tion, whereas the fifth region considered in this study, Tumaco,
which is a Pacific coastal region, represents most of the black
population enrolled for this work (Figure 1).
The aim of this study was to assess the number of simultaneous
infections in a sample of 1,810 colombian women, which as
mentioned in the previous paragraph, come from different regions.
With these data, we determined epidemiological profiles of some
risk factors associated with possible coinfection patterns.
Results
Of the total number of women who voluntarily agreed to
participate in this study (n = 2,110), cervical samples collected from
1,815 women had optimal DNA quality according to b globin
gene amplification. Five samples were excluded from the analysis
taking into account that they were reported as undetermined in
the specific viral type identification; therefore, 1,810 were
considered for the statistical analysis. The mean age of these
women was 39612 years, being the youngest 14 years old and the
oldest 77 years old. Sociodemographic and clinical data of women
participating in this study are shown in Table 1.
The HPV prevalence among these women was 49.9% (CI 95%:
47.1%–51.7%), with HPV-16 being the most frequently detected
Figure 1. Geographic localization of the five populations included in this study (modified from [49]).
doi:10.1371/journal.pone.0014705.g001
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type (Table 1). Of the total number of infected women, 65.2% (CI
95%: 62%–68.3%) were infected with multiple HPV types. A
previous study on this population had found that infections with
multiple HR-HPV types are more frequently associated with types
belonging to the A7 species [14]. Compared to expected
frequencies and assuming a Negative Binomial distribution, the
observed number of women having a single infection (one HPV
type) was significantly smaller than expected. For infections with
two, three or four HPV types, observed frequencies were generally
larger, while detection of more than four viral types in a single
woman was much lower than expected (Table 2).
Since the likelihood–ratio test for alpha = 0 (x2(1) = 221.60;
P = 0.000) indicated over dispersion, a robust negative binomial
regression model was applied to predict the number of infections
per woman (a count outcome). This model was evaluated
considering all explanatory variables (age, smoking, lifetime
number of sexual partners, age at first intercourse, number of
pregnancies, ethnicity, contraceptive method, marital status and
cytology). The regression model that best predicted the number of
HPV infecting types included ethnicity and number of pregnancies
(Table 3).
The coefficients for this model are shown in Table 3, as the
percentage change in the number of HPV infecting types. When
all other variables were maintained constant, having had 1 or
more pregnancies decreased the expected number of HPV
infecting types, compared to women with no pregnancies.
Regarding ethnicity, the expected number of HPV infecting types
increased in indigenous women by 37.8% when compared to
white women, whereas this number decreased in black and
mestizo women (40.9% and 24.6%, respectively).
Discussion
The extended access to HPV vaccines against certain specific
HPV types has motivated studies to determine cross-protection
conferred by such vaccines and the role of multiple HPV infections
in the development of cervical lesions. It has been demonstrated
that there is a direct association between the severity of a lesion
and coinfection events, which has been shown to depend on the
number of HPV infecting types. Such association has been
observed both in coinfections with HR-HPV types, as well as with
low risk (LR) types [19]. Follow-up studies have reported that
those women infected with one HPV type at the beginning of the
study have an increased risk of acquiring a second HPV type [21].
Even though it is wide known that HPV infection prevalence
varies in different regions given the population characteristics and
the techniques used for detection, this study shows similar data to
those reported for Latin America in the last two years, in which
infection rates equal or greater than 50.0% were found [22,23]. As
has been previously described, using more than one generic primer
set allowed us to detect a greater number of infected women [24],
as well as a better coinfection estimate [25].
The clinical importance of coinfection in cervical cancer
etiology has been cause of extensive debate. There are reports of
patients with multiple cervical intraepithelial lesions of different
grades [20], but their association with coinfection events is still not
clear. Despite coinfection is seldom reported in cervical cancer
[26–28], several studies have shown an association between HPV
coinfection and the increase in the lesion severity [29,30].
Although the findings mentioned above might seem contradictory,
a possible explanation might be that HPV coinfection could favor
the settlement of one of the infecting viruses, given that tumors are
usually clonal and thus reflect only 1 HPV type. This notion is
supported by previous studies where infections caused by some
viral types are favored by a previous infection with other types
[31]. These data, plus the partial protection of the currently
Table 1. Sociodemographic characteristics, HPV DNA testing
and Pap testing results for the 1810 women included in this
study.
Characteristics n (%)*
,20 57 (3%)
Age 20–40 865 (49%)
.40 849 (48%)
Smoking Yes 198 (11%)
No 1607 (89%)
Lifetime 1 745 (43%)
number of 2–3 816 (47%)
sexual partners .3 179 (10%)
Age at first $18 860 (49%)
intercourse ,18 895 (51%)
0 116 (7%)
Pregnancies 1–2 619 (36%)
3–4 618 (35%)
.4 388 (22%)
White 302 (17%)
Ethnicity Indigenous 46 (3%)
Mestizo 1054 (59%)
Black 378 (21%)
None 728 (42%)
Contraceptive Hormonal 185 (11%)
method Surgery 536 (31%)
Barrier 277 (16%)
Single 299 (17%)
Married 408 (23%)
Marital status Civil Union 896 (50%)
Divorced 137 (8%)
Widow 45 (2%)
Normal Cytology 1564 (91%)
Pap smear ASCUS** 92 (5%)
results LSIL{ 49 (3%)
HSIL{ 13 (1%)
HPV-16 834 (42%)
Typing results HPV-18 268 (14%)
for HPV-DNA HPV-31 290 (15%)
positive HPV-33 194 (10%)
samples1 HPV-45 172 (9%)
HPV-58 94 (5%)
HPV-6/11 100 (5%)
TOTAL 1810
*Categories have a size lower than 1810, given that there are missing data on
the surveys.
**Atypical squamous cells of undetermined significance (ASCUS).
{Low squamous intraepithelial lesion (LSIL).
{High squamous intraepithelial lesion (HSIL).
1Percentages correspond to infection events with each HPV type, calculated
over a total of 1952 infections, given that some women were coinfected.
doi:10.1371/journal.pone.0014705.t001
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available vaccines, support studying multiple HPV infections more
in depth, as well as determine the risk factors associated to them.
A similar HPV prevalence for each Pap smear category was
found. The absence of a greater viral presence in the HSIL group
might be explained by GP5+/6+ and MY09/11 primer sets’
amplification targets, both of which lie within the L1 encoding
gene. It has been shown that viral DNA is mainly integrated to the
host genome in high-degree lesions, leading to the partial loss of
the L1 ORF [32,33].
In this study, observed frequencies for the number of infecting
genotypes according to a binomial negative distribution, were larger
than expected for the group of women coinfected with 4 viral types or
less, but smaller for the group of women with a single infection; this
trend could be considered as another marker for the high frequency of
coinfection present in the population studied. In contrast, the group
with women coinfected with more than 4 viral types showed observed
frequencies lower than expected, which could be attributed to a greater
exposure of this population to the most widely distributed viral types.
A previous study reported by Chaturvedi et al., has shown a
similar HPV distribution pattern between HIV(+) and HIV(-)
women [34], leading us to suggest that such pattern is not
necessarily related to the host immunological condition, but rather
Table 2. Number of Observed and Expected data according to a Negative Binomial distribution.
Negative Binomial
distribution frequencies Number of viral types detected by PCR in the cervical sample
0 1 2 3 4 .4 x2
CHARACTERISTICS Obs Esp Obs Esp Obs Esp Obs Esp Obs Esp Obs Esp (5df) p =
,20 27 26 8 14 9 8 10 4 3 2 0 1 10.74 p = 0.05
Age 20–40 434 430 161 216 150 109 73 55 40 27 7 14 12.94 p=0.02
.40 436 405 133 212 132 111 77 58 53 30 18 16 11.17 p = 0.05
Smoking Yes 105 100 33 49 33 25 15 12 9 6 3 3 12.94 p=0.02
No 808 779 278 401 264 207 147 107 88 55 22 28 12.5 p=0.03
N6 Lifetime 1 362 346 115 185 128 99 83 53 48 28 9 15 11.09 p = 0.05
sexual 2–3 439 417 145 204 122 100 62 49 34 24 14 12 21.32 p=0.01
partners .3 88 87 35 45 28 23 15 12 12 6 1 3 12.5 p=0.03
Age at first $18 years 441 431 158 215 139 107 76 54 36 27 10 13 12.94 p=0.02
intercourse ,18 years 452 424 140 223 145 117 84 62 60 32 14 17 11.12 p = 0.05
0 48 51 25 29 22 16 9 9 9 5 3 3 10.78 p = 0.06
Pregnancies 1–2 316 306 104 155 104 78 63 40 26 20 6 10 12.55 p=0.03
3–4 309 298 113 154 94 80 55 41 38 21 9 11 11.17 p = 0.05
.4 208 191 59 97 59 49 33 25 22 13 7 6 12.55 p=0.03
White 150 131 36 74 41 42 36 24 28 13 11 8 7.2 p = 0.20
Indigenous 17 17 4 11 8 7 9 4 6 3 2 2 4.75 p = 0.44
Ethnicity Mestizo 539 524 186 263 177 132 92 67 51 33 9 17 12.94 p=0.02
Black 196 202 82 94 67 44 21 20 9 10 3 4 21.92 p=0.01
None 372 357 128 182 119 93 58 47 40 24 11 12 12.55 p=0.03
Contraceptive Hormonal 86 87 34 46 39 24 11 13 13 7 2 4 11.12 p = 0.05
method Surgery 282 264 95 134 68 68 52 35 28 18 11 9 12.55 p=0.02
Barrier 136 132 42 69 50 36 34 19 14 10 1 5 11.17 p = 0.05
Single 154 141 43 75 42 39 37 21 18 11 5 6 11.15 p=0.01
Marital Married 203 196 65 102 77 53 32 28 28 14 3 7 11.17 p = 0.05
status Civil Union 453 447 172 224 151 112 66 56 40 28 14 14 12.94 p=0.02
Divorced 77 71 23 34 15 17 15 8 4 4 3 2 21.32 p=0.01
Widow 19 20 8 11 10 6 5 3 3 2 0 1 10.74 p = 0.05
Normal
Citology
787 758
265 391 268 201 136 104 86 54 22 28 11.17 p = 0.05
Pap smears ASCUS** 39 44 23 23 16 12 8 7 6 3 0 2 10.88 p = 0.05
results LSIL{ 22 22 9 12 5 7 9 4 3 2 1 1 8.03 p = 0.16
HSIL{ 5 5 1 3 1 2 4 2 1 1 1 1 4.28 p = 0.51
TOTAL 916 881 311 452 298 232 162 119 98 61 25 31 12.55 p=0.03
*Data with p,0.05 are shown in bold types.
**Atypical squamous cells of undetermined significance (ASCUS).
{Low squamous intraepithelial lesion (LSIL).
{High squamous intraepithelial lesion (HSIL).
doi:10.1371/journal.pone.0014705.t002
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to the natural history of HPV infection; however, more studies
including statistical distributions are needed to shed some light on
this matter.
An important conclusion obtained from the multivariate
analysis was the decreased risk of acquiring more viral types in
women who had given birth one or more times. High parity has
been usually associated with the risk of developing cervical cancer,
based on the notion that a large number of births increases the
number of lesions in the birth canal or causes immunosuppression
in such area (reviewed in [2]). However, according to a study
conducted by Molano et al., the risk of acquiring infections with
high risk HPV types, as well as coinfections, tends to diminish with
the number of births [13]. This agrees with the results of the
present study, which show that the risk of being infected with a
large number of HPV types decreased to 31.1% in women who
had given birth 4 or more times, compared to women who had not
given birth. An explanation to this observation could be associated
with riskier sexual behaviors in the latter group of women (e.g.
large number of sexual partners during a woman’s lifetime).
However, this conclusion should be taken with caution because
there are not sufficient studies relating the number of births with
coinfection, or coinfection with hormonal conditions after labor.
Another important aspect to consider is the increase of a 37.8%
in the number of infecting HPV types found in women of
indigenous ethnicity, and the decrease of 24.6% and 40.9% in
women of mestizo and black ethnicities, respectively, compared to
white women. These findings could be influenced by sociocultural
and demographic conditions intrinsic to these ethnic groups [35].
The indigenous ethnicity appears to play an important role in the
association of infection, possibly due to cultural characteristics,
such as limited access to prevention and promotion programs of
cervical cancer and sexually transmitted diseases, early start of
sexual relationships and childbirth, or intrinsic biological charac-
teristics of this particular ethnia, which contribute to the immune
system modulation and might suppress the immune response, thus
facilitating the viral infection [36,37].
Regarding this later aspect, few studies have focused on the
susceptibility to coinfection in different ethnic groups. There are
reports showing that black women display a certain degree of
protection against HPV infection when compared to hispanic ones
[38,39], agreeing with our findings. However, other studies carried
out with black women reported that infections found in this
population are higher [40]. There are no studies which assess the
true HPV prevalence in black women in different geographical
regions, since most of recent studies carried out with black women
are focused in vaccination and post-vaccination monitoring.
Taking into account a study carried out by Kenney in 1996, in
which risk factors associated to infections were assessed in different
ethnic groups, it can be inferred that black women have more risk
to acquire infections due to their sexual behavior. In average,
black women have more life time sexual partners than hispanic
women, their actual sexual partners have had more lifetime sexual
partners and cigarette smoking is higher in this population. On the
other hand, black women that acquire infection have been taking
oral contraceptives longer than hispanic women who also develop
infection [36]. It is necessary to corroborate these statements in the
light of statistical significance. HPV infection susceptibility in black
women has been also contradictory from the host genetic
background, since there are studies that reported HLA-class-II
DQB1*03 alleles both as a risk factor [41,42] and a protective
factor [43]. Further studies are required to establish the real role of
infection in this ethnic group.
For Latin America in particular, some studies have examined
the role of genes, especially HLA haplotypes in the risk of
acquiring HPV infections [44–46]. Studies conducted in Brazil
have reported major histocompatibility complex alleles involved in
susceptibility and protection against HPV infections [47]. In
Colombia, no studies have been conducted to identify autochtho-
nous genetic factors related to the predisposition to acquire single
or multiple HPV infections to date.
We found a strong association between multiple HPV infections
and indigenous ethnicity in a previous study, where the same
population described here was analyzed [14]; however, no
association with other ethnicities was found. The different
outcomes might have been due to a different dependant variable,
which in this case is the number of HPV infecting types. Low-risk
infections were not considered in the previous study.
This study reports an important association between the risk of
acquiring infection with multiple HPV types and the indigenous
ethnicity, which highlights the importance of focusing studies in
this vulnerable population. Nevertheless the transversal design of
this study prevents detecting neither acquisition patterns of more
than one HPV type nor its relationship with the different risk
factors, which make it relevant to conduct longitudinal studies to
detect the moment when the acquisition of other HPV types occur
and determine if infection events take place simultaneously. Here
we report that the infection cases observed with 2 to 4 HPV types
are greater than the expected, which suggests the importance of
carrying out an analysis of infecting species. Even though we did
not assess the distribution of coincident HPV types in our study,
our group has reported two studies in which this topic is discussed
[14,48].
The analysis carried out in this study is important since few
studies have compared the risk factors associated with single and
multiple HPV infections in socioculturally diverse populations as
the one existing in Colombia.
Materials and Methods
Study population and ethical considerations
This study enrolled women living in five geographical regions of
Colombia attending to their cervical screening consult between
April and September of 2007. These five populations have been
described elsewhere [14]. Prior to undergoing gynecological
examination, all women signed a written informed consent and
filled out a questionnaire regarding sociodemographic character-
istics, sexual behaviors and risk factor data (Table 1). An informed
consent was signed by a parent or guardian in the case of children
under age. Each women voluntarily agreed to provide a sample of
cervical epithelium which was analyzed by Papanicolau testing
and HPV–DNA detection. This study was conducted with the
supervision and approval of each institution’s Ethics Committee,
Table 3. Negative binomial regression model.
X variables Coef. P.z [95% CI]* %**
1–2 pregnancies 20.319750 0.004 20.537142 20.102358 227.4
3–4 pregnancies 20.327596 0.004 20.553170 20.102022 227.9
.4 pregnancies 20.372914 0.004 20.629364 20.116465 231.1
Indigenous 0.320354 0.041 0.013561 0.627147 37.8
Mestizo 20.282646 0.001 20.444652 20.120641 224.6
Black 20.526085 0.000 20.730887 20.321284 240.9
*CI: Confidence Intervals.
**Percent change in expected count for unit increase in X.
doi:10.1371/journal.pone.0014705.t003
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as follows: the Ethics Committee of Fundacio´n Instituto de
Inmunologı´a de Colombia, Bioethics Committee of the League
Against Cancer - Amazon Sectional, The Ethics Committee of
Nuevo Hospital San Rafael E.S.E - Girardot, Bioethics Committee
of Hospital San Juan Bautista de Chaparral E.S.E, Hospitalary
Ethics Committee of Hospital de Engativa´ Nivel II and Ethics
Committee of Hospital San Andres, Tumaco E.S.E.
Detection of HPV DNA by PCR amplification
Cervical samples were collected with a cytobrush and stored in
95% ethanol at 4uC [49]. DNA from these samples was digested
with lysis buffer containing 10 mM Tris–HCl (pH 7.9), 0.45%
Nonidet–P-40, 0.45% Tween 20 and 60 mg/mL of Proteinase K
(Invitrogen, California, USA), first at 60uC for 1 h and then at
95uC for 10 min [50]. A 2.7-mL aliquot of each processed sample
was amplified by PCR using the human b-globin GH20/PC04
primers to check DNA integrity [51] and two HPV generic primer
sets were employed for detection, to prevent underestimation in
the determination of viral prevalence caused by the use of a single
HPV identification set [52]. These sets are: GP5+/GP6+ which
allows detecting low viral loads [51,53] and MY09/MY11 which
has higher sensitivity for detecting infections with more than one
viral type [25]. Additionally, these generic primer sets are easily
implemented and increase robustness and sensibility to epidemi-
ological studies [24,54]. Despite the advantages obtained, it is
worth noting that the use of multiple primer sets can also increase
contamination, which is why protocols aimed at minimizing this
contamination must be followed. In the present study, negative
and positive controls were run every 46 samples, and whenever
either control gave an unexpected result, the whole series was
repeated. Samples testing positive with one or both generic primer
sets underwent PCR amplification with type-specific primers for
HPV-6/-11, -16, -18, -31, -33, -45 and -58 annealing within the
E5, E6 and E7 regions [4,24,55,56], Studies carried out in Latin
America have found that the 6 high-risk viral types included in this
study are present in the 90% of cases of cervical cancer [57].
Synthetic genes encoding HPV-18, -31, -45 and -58 early regions
and HPV-6/-11, -16 and -33 infected samples were used as
positive controls for type-specific PCR reactions [58]. This PCR
procedure was carried out in duplicate and DNA-free water was
used as negative control to rule out DNA contamination.
Statistical analysis
Descriptive statistics were used to evaluate demographic and
clinical characteristics of the population. The expected number of
coinfecting genotypes was estimated assuming a negative binomial
distribution. Although previous studies used a Poisson model to
evaluate the fit of data [34], in our sample the over dispersion
coefficient alpha was significantly different from zero for all of the
variables included in the analysis. The difference between
observed vs. expected frequencies was evaluated using a one-way
x2 Goodness-of-fit test.
In order to evaluate which explanatory variables (age, smoking,
lifetime number of sexual partners, age at first intercourse, number
of pregnancies, ethnicity, contraceptive method, marital status and
cytology) were associated with the number of coinfections
(dependent variable), a negative binomial model was used instead
of a Poisson distribution, since this model does not consider the
existence of over dispersion (in our data the mean/variance ratio
was 0.7) [59]. Additionally, a likelihood ratio test was used to
compare the relative fit of the Poisson model to the negative
binomial model. The negative binomial model assumes that the
number of coinfections is a count outcome. The use of this model
is preferred over other tests that estimate ORs, given both the
count outcome and the high frequencies of the expected outcomes
[60]. All the statistical analyses were performed using STATA 9H.
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